EX-99.A 2 d417722dex99a.htm EX-A EX-A
CUSIP No. 02083G100    SCHEDULE 13D   

 

EXHIBIT A

JOINT FILING AGREEMENT

The undersigned hereby agree that the statement on Schedule 13D with respect to the common stock, $0.001 par value per share of Alpine Immune Sciences, Inc. dated as of August 3, 2017 is, and any amendments thereto (including amendments on schedule 13G) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

Date: August 3, 2017

 

ALPINE IMMUNOSCIENCES, L.P.
By: Alpine BioVentures, GP, LLC, its general partner
By:   /s/ Mitchell H. Gold

Name:

  Mitchell H. Gold

Title:

  Manager
ALPINE BIOVENTURES, GP, LLC
By:   /s/ Mitchell H. Gold

Name:

  Mitchell H. Gold

Title:

  Manager

 

MITCHELL H. GOLD

/s/ Mitchell H. Gold

JAY VENKATESAN

/s/ Jay Venkatesan